Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
09:30:27 2026-08-17 am EDT
|
5-day change | 1st Jan Change | ||
| 1.630 USD | -1.81% |
|
-4.12% | +32.50% |
| Market Cap | 45.98M 39.72M 37.32M 33.94M 63.81M 4.4B 64.86M 437M 171M 2.2B 173M 169M 7.32B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.66M 38.57M 36.25M 32.97M 61.98M 4.27B 63M 425M 166M 2.14B 168M 164M 7.11B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.81% | ||
| 1 week | -4.12% | ||
| Current month | +7.45% | ||
| 1 month | +6.89% | ||
| 3 months | -6.86% | ||
| 6 months | -10.62% | ||
| Current year | +32.50% |
| 1 week | 1.6 |  | 1.7 |
| 1 month | 1.34 | | 1.7 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | -4.12% | +79.57% | -3.55% | 45.98M | |
| +2.01% | -1.52% | +94.55% | +503.27% | 44.67B | |
| +1.65% | +0.42% | +19.29% | +51.55% | 25.8B | |
| +1.97% | +1.83% | -19.96% | -28.79% | 7.84B | |
| -0.55% | -1.62% | +14.69% | +159.13% | 6.01B | |
| -2.04% | -3.93% | +9.51% | +66.25% | 3.35B | |
| +1.31% | +0.19% | -38.02% | +1,418.09% | 2.33B | |
| -1.57% | +3.76% | -0.33% | -53.47% | 2.06B | |
| +1.32% | -3.79% | +156.41% | +17.13% | 2.05B | |
| -0.38% | -3.45% | +28.23% | +20.33% | 1.89B | |
| Average | +0.16% | -0.49% | +34.39% | +215.00% | 9.6B | |
| Weighted average by Cap. | +1.40% | -1.67% | +51.78% | +291.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.53M 38.09M 34.64M 65.12M 4.49B 66.19M 446M 174M 2.25B 176M 172M 7.47B | 38.73M 33.45M 31.43M 28.59M 53.74M 3.7B 54.63M 368M 144M 1.85B 145M 142M 6.16B |
| Net income | 6.7M 5.79M 5.44M 4.95M 9.3M 641M 9.45M 63.73M 24.92M 321M 25.16M 24.62M 1.07B | 24.58M 21.23M 19.95M 18.14M 34.1M 2.35B 34.67M 234M 91.37M 1.18B 92.27M 90.26M 3.91B |
| Net Debt | 4.4M 3.8M 3.57M 3.24M 6.1M 420M 6.2M 41.8M 16.34M 210M 16.5M 16.14M 699M | -1.32M -1.14M -1.07M -976K -1.83M -126M -1.86M -12.57M -4.92M -63.3M -4.96M -4.86M -210M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | $1.630 | -1.81% | 5,700 |
| 26-08-14 | $1.660 | -0.60% | 21,706 |
| 26-08-13 | $1.670 | 0.00% | 24,225 |
| 26-08-12 | $1.670 | +0.06% | 2,103 |
| 26-08-11 | $1.669 | -1.82% | 18,248 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
